JP2012528828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528828A5 JP2012528828A5 JP2012513613A JP2012513613A JP2012528828A5 JP 2012528828 A5 JP2012528828 A5 JP 2012528828A5 JP 2012513613 A JP2012513613 A JP 2012513613A JP 2012513613 A JP2012513613 A JP 2012513613A JP 2012528828 A5 JP2012528828 A5 JP 2012528828A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrid
- pharmaceutical composition
- benign
- methyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18414109P | 2009-06-04 | 2009-06-04 | |
| US61/184,141 | 2009-06-04 | ||
| PCT/EP2010/057719 WO2010139731A1 (en) | 2009-06-04 | 2010-06-02 | 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528828A JP2012528828A (ja) | 2012-11-15 |
| JP2012528828A5 true JP2012528828A5 (https=) | 2014-07-03 |
| JP5596137B2 JP5596137B2 (ja) | 2014-09-24 |
Family
ID=42697442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513613A Expired - Fee Related JP5596137B2 (ja) | 2009-06-04 | 2010-06-02 | １Ｈ−イミダゾ［４，５−ｃ］キノリノン誘導体 |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US8476294B2 (https=) |
| EP (1) | EP2438064A1 (https=) |
| JP (1) | JP5596137B2 (https=) |
| KR (1) | KR101445458B1 (https=) |
| CN (1) | CN102574845B (https=) |
| AR (1) | AR076949A1 (https=) |
| AU (1) | AU2010255727B2 (https=) |
| BR (1) | BRPI1010621A2 (https=) |
| CA (1) | CA2763821A1 (https=) |
| CL (1) | CL2011003052A1 (https=) |
| CO (1) | CO6470887A2 (https=) |
| CR (1) | CR20110608A (https=) |
| CU (1) | CU24064B1 (https=) |
| DO (1) | DOP2011000373A (https=) |
| EA (1) | EA020715B1 (https=) |
| EC (1) | ECSP11011500A (https=) |
| GE (1) | GEP20156267B (https=) |
| IL (1) | IL216452A0 (https=) |
| MA (1) | MA33332B1 (https=) |
| MX (1) | MX2011012943A (https=) |
| NI (1) | NI201100209A (https=) |
| NZ (1) | NZ596487A (https=) |
| PE (1) | PE20120224A1 (https=) |
| SG (1) | SG176572A1 (https=) |
| TN (1) | TN2011000626A1 (https=) |
| TW (1) | TWI464168B (https=) |
| UA (1) | UA106074C2 (https=) |
| UY (1) | UY32682A (https=) |
| WO (1) | WO2010139731A1 (https=) |
| ZA (1) | ZA201108439B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010035744A1 (de) * | 2010-08-28 | 2012-03-01 | Merck Patent Gmbh | Imidazolonylchinoline |
| JP2014504286A (ja) * | 2010-12-06 | 2014-02-20 | ピラマル エンタープライジーズ リミテッド | 置換イミダゾキノリン誘導体 |
| JO3003B1 (ar) | 2011-01-14 | 2016-09-05 | Lilly Co Eli | مركب أيميدازو [4، 5 -c ] كينولين-2- واحد واستخدامه كمثبط كيناز PI3/mtor |
| WO2013071698A1 (zh) | 2011-11-17 | 2013-05-23 | 山东轩竹医药科技有限公司 | 三环类PI3K和/或mTOR抑制剂 |
| WO2014141118A1 (en) * | 2013-03-14 | 2014-09-18 | Piramal Enterprises Limited | Imidazo[4,5-c]quinoline derivatives and uses thereof |
| BR112015025686B1 (pt) | 2013-04-15 | 2020-10-27 | Fmc Corporation | composto, composições fungicidas e método para o controle das doenças dos vegetais |
| JP6576929B2 (ja) * | 2013-09-11 | 2019-09-18 | メルク パテント ゲーエムベーハー | ヘテロ環化合物 |
| US9745321B2 (en) | 2013-09-30 | 2017-08-29 | Shanghai Yingli Pharmaceutical Co., Ltd | Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof |
| JP6606428B2 (ja) * | 2013-10-11 | 2019-11-13 | 国立大学法人 東京医科歯科大学 | 脊髄小脳変性症を予防又は治療するための薬剤 |
| CN104447740B (zh) | 2013-11-20 | 2017-02-22 | 北京富龙康泰生物技术有限公司 | 咪唑酮类衍生物、其药物组合物和用途 |
| NO2714752T3 (https=) | 2014-05-08 | 2018-04-21 | ||
| JP6195684B2 (ja) | 2014-06-03 | 2017-09-13 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ピラゾール化合物及びｔ型カルシウムチャンネルブロッカーとしてのそれらの使用 |
| PL3560924T3 (pl) * | 2015-04-02 | 2021-10-11 | Merck Patent Gmbh | Imidazolonylochinoliny i ich zastosowanie jako inhibitorów kinazy atm |
| GB201516504D0 (en) * | 2015-09-17 | 2015-11-04 | Astrazeneca Ab | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer |
| GB201519568D0 (en) * | 2015-11-05 | 2015-12-23 | Astrazeneca Ab | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| BR112019007594A2 (pt) | 2016-10-13 | 2019-07-02 | Loyola University Of Chicago | método para bloquear a transmissão do parasita da malária |
| CN110072521B (zh) | 2016-12-16 | 2022-11-29 | 爱杜西亚药品有限公司 | 包含t型钙通道阻断剂的药物组合 |
| MA47409A (fr) | 2017-02-06 | 2019-12-11 | Idorsia Pharmaceuticals Ltd | Nouveau procédé de synthèse de 1-aryl-1-trifluorométhylcyclopropanes |
| JOP20190209A1 (ar) * | 2017-03-16 | 2019-09-12 | Astrazeneca Ab | مركبات إيميدازو [ 4، 5-c ] كينولين-2-أون ديوترومية واستخدامها في علاج السرطان |
| EP3728228A1 (en) | 2017-12-22 | 2020-10-28 | Ravenna Pharmaceuticals, Inc. | Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| CN115151253B (zh) * | 2019-09-23 | 2025-04-15 | 南京征祥医药有限公司 | 磷酸二酯酶抑制剂及用途 |
| ES2974742T3 (es) | 2020-09-21 | 2024-07-01 | Wei Zhong | Compuestos de 1-(3,3-difluoropiperidin-4-il)-imidazo[4,5-c]quinolin-2-ona sustituidos con capacidad de penetración en la barrera hematoencefálica |
| CN115136336A (zh) * | 2021-01-26 | 2022-09-30 | 京东方科技集团股份有限公司 | 量子点发光器件、显示装置和制作方法 |
| CN116768928A (zh) * | 2023-06-15 | 2023-09-19 | 上海毕臣生化科技有限公司 | 一种3-叔丁基-5-硼酸酯基吡啶的合成方法 |
| CN117384154A (zh) * | 2023-09-04 | 2024-01-12 | 广州医科大学 | 一种吡咯并喹啉酮化合物、合成方法及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211649D0 (en) | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
| DE602004014969D1 (de) | 2003-11-21 | 2008-08-21 | Novartis Ag | 1h-imidazochinolinderivate als proteinkinaseinhibitoren |
| AR046845A1 (es) * | 2003-11-21 | 2005-12-28 | Novartis Ag | Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas |
| US20080213308A1 (en) | 2004-09-14 | 2008-09-04 | Nicholas Valiante | Imidazoquinoline Compounds |
| GB0510390D0 (en) * | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| KR20080083270A (ko) | 2005-11-04 | 2008-09-17 | 콜레이 파마시티컬 그룹, 인코포레이티드 | 하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법 |
| RS53335B (sr) | 2006-11-20 | 2014-10-31 | Novartis Ag | Kristalna monotozilatna so 2-metil-2-[4-(3-metil-2-okso-8-hinolin-3-il-2,3-dihidro-imidazo[4,5-c]hinolin-1-il)-fenil]-propionitrila |
| US9370508B2 (en) * | 2007-02-20 | 2016-06-21 | Novartis Ag | Imidazoquinolines as dual lipid kinase and mTOR inhibitors |
| JP2010534219A (ja) * | 2007-07-24 | 2010-11-04 | ノバルティス アーゲー | Ｅｇｆｒ依存性疾患またはｅｇｆｒファミリーメンバーを標的とする薬剤に対して耐性を獲得した疾患の処置のための、イミダゾキノリンの使用 |
| US20090082387A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched nvp-bez234 |
| BRPI0909082A2 (pt) | 2008-03-26 | 2019-02-26 | Novartis Ag | imidazoquinolinas e derivados de pirimidina como moduladores potentes de processos angiogênicos acionados por vegf |
| EP2303890A4 (en) | 2008-06-19 | 2012-04-11 | Progenics Pharm Inc | INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE |
| WO2010038165A1 (en) * | 2008-09-30 | 2010-04-08 | Pfizer Inc. | Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
-
2010
- 2010-06-02 NZ NZ596487A patent/NZ596487A/xx not_active IP Right Cessation
- 2010-06-02 PE PE2011002047A patent/PE20120224A1/es not_active Application Discontinuation
- 2010-06-02 SG SG2011085487A patent/SG176572A1/en unknown
- 2010-06-02 CA CA2763821A patent/CA2763821A1/en not_active Abandoned
- 2010-06-02 EA EA201101704A patent/EA020715B1/ru not_active IP Right Cessation
- 2010-06-02 GE GEAP201012484A patent/GEP20156267B/en unknown
- 2010-06-02 JP JP2012513613A patent/JP5596137B2/ja not_active Expired - Fee Related
- 2010-06-02 CN CN201080034616.0A patent/CN102574845B/zh not_active Expired - Fee Related
- 2010-06-02 AU AU2010255727A patent/AU2010255727B2/en not_active Ceased
- 2010-06-02 US US12/792,471 patent/US8476294B2/en not_active Expired - Fee Related
- 2010-06-02 KR KR1020127000098A patent/KR101445458B1/ko not_active Expired - Fee Related
- 2010-06-02 MA MA34404A patent/MA33332B1/fr unknown
- 2010-06-02 WO PCT/EP2010/057719 patent/WO2010139731A1/en not_active Ceased
- 2010-06-02 UA UAA201114398A patent/UA106074C2/uk unknown
- 2010-06-02 EP EP10721029A patent/EP2438064A1/en not_active Withdrawn
- 2010-06-02 BR BRPI1010621A patent/BRPI1010621A2/pt not_active IP Right Cessation
- 2010-06-02 MX MX2011012943A patent/MX2011012943A/es active IP Right Grant
- 2010-06-02 AR ARP100101942A patent/AR076949A1/es unknown
- 2010-06-03 UY UY0001032682A patent/UY32682A/es not_active Application Discontinuation
- 2010-06-03 TW TW099117977A patent/TWI464168B/zh not_active IP Right Cessation
-
2011
- 2011-11-17 ZA ZA2011/08439A patent/ZA201108439B/en unknown
- 2011-11-17 IL IL216452A patent/IL216452A0/en not_active IP Right Cessation
- 2011-11-21 CR CR20110608A patent/CR20110608A/es unknown
- 2011-11-30 NI NI201100209A patent/NI201100209A/es unknown
- 2011-11-30 CU CU2011000221A patent/CU24064B1/es not_active IP Right Cessation
- 2011-12-02 EC EC2011011500A patent/ECSP11011500A/es unknown
- 2011-12-02 CL CL2011003052A patent/CL2011003052A1/es unknown
- 2011-12-02 DO DO2011000373A patent/DOP2011000373A/es unknown
- 2011-12-05 TN TNP2011000626A patent/TN2011000626A1/en unknown
- 2011-12-12 CO CO11170918A patent/CO6470887A2/es active IP Right Grant
-
2013
- 2013-05-24 US US13/901,849 patent/US20140005163A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528828A5 (https=) | ||
| AU2020250211B2 (en) | Bicyclic heterocycles as fgfr inhibitors | |
| KR101466412B1 (ko) | 피롤로피리미딘 화합물 및 그의 용도 | |
| US8188113B2 (en) | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| ES2682493T3 (es) | Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de FGFR4 | |
| KR101445458B1 (ko) | １Ｈ-이미다조［４,５-ｃ］퀴놀리논 유도체 | |
| IL303451A (en) | Prmts inhibitors | |
| AU2010269674B2 (en) | Azabicyclo compound and salt thereof | |
| US20220348573A1 (en) | Fgfr4 inhibitor, preparation method therefor and pharmaceutical use thereof | |
| EA032416B1 (ru) | Соединения триазолопиримидина и их применения | |
| MX2015004151A (es) | Inhibidores del factor de diferenciacion de crecimiento-8 (gdf-8). | |
| AU2007296441A1 (en) | Kinase inhibitors useful for the treatment of proliferative diseases | |
| CN111683950B (zh) | AhR调节剂 | |
| RS55863B1 (sr) | Inhibitori kinaze pirazolil hinoksalina | |
| KR20160012194A (ko) | 이미다조피롤리디논 유도체 및 질환의 치료에서의 그의 용도 | |
| CN105777756A (zh) | 杂芳化合物及其在药物中的应用 | |
| AU2012299899A1 (en) | Bicyclic heteroaromatic compounds | |
| JP2024023699A (ja) | 環式化合物およびその使用方法 | |
| ES2586527T9 (es) | Compuestos heterocíclicos y uso de los mismos como moduladores del receptor de tirosina quinasas de tipo III | |
| WO2010000364A1 (de) | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate | |
| KR102590854B1 (ko) | Crhr2 길항제로서의 축합 환상 요소 유도체 | |
| JP2022539208A (ja) | チロシンキナーゼ非受容体１（ｔｎｋ１）阻害剤およびその使用 | |
| EA052528B1 (ru) | Циклические соединения и способы их применения | |
| CN117897159A (zh) | 杂环化合物及使用方法 | |
| BR112017017418B1 (pt) | Heterociclos bicíclicos como inibidores de fgfr, seu uso e composição farmacêutica que os compreende |